E&C Required Pledge Of Support For Entry Into LDT Stakeholder Meeting

February 5, 2016 at 2:43 PM
The House Energy & Commerce Committee required stakeholder groups to pledge in writing their support for the committee's proposed framework for oversight of laboratory developed tests prior to admittance into a bipartisan meeting last month that also included FDA, multiple sources confirm to Inside Health Policy. Groups at the meeting spearheaded by E&C were invited based on whether they submitted positive, non-adversarial, comments following the hearing the committee held on LDTs last fall, sources said, but entry was limited...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.